IDT AUSTRALIA LIMITED — Investor Relations & Filings

IDT Australia Limited specializes in the development and manufacture of high-potency active pharmaceutical ingredients (APIs) and finished dosage forms. The organization provides integrated services encompassing analytical chemistry, microbiology, clinical trial supply, and commercial-scale production. Utilizing facilities inspected by global regulatory bodies, the company supports biotechnology and pharmaceutical partners throughout the product lifecycle, from initial formulation to large-scale manufacturing. Technical expertise includes the containment and processing of cytotoxic and high-potency compounds, alongside capabilities in mRNA technology and liquid-fill operations. The company focuses on the delivery of complex drug products and specialty medicines, emphasizing technical precision and regulatory adherence to meet the requirements of international markets.